Europe PMC
metadata only
Low-Strength Type I Interferon Signaling Promotes CAR T-cell Treatment Efficacy
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia#356486
- CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma#253055
- Integrating AI, RNA Vaccines, and CAR‐T Cells for Personalized Treatment#643277
- The role of cytokines for clinical CAR-T cell manufacturing: systematic review and analysis of current evidence#360965
- GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma#813071
Record · ID 485313
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive